BioCentury | Jan 10, 2013
Distillery Therapeutics

Indication: Cardiovascular disease

...modulating necrosis via SIRT2 inhibition could have benefit in other indications, such as neurodegenerative diseases. Indus Biotech Pte. Ltd.'s...
BioCentury | Sep 20, 2012
Distillery Therapeutics

Indication: Neurology

...of Sirt2 deletion in other mouse models of PD and developing selective, brain-penetrant SIRT2 inhibitors. Indus Biotech Pte. Ltd....
BioCentury | Jun 28, 2012
Distillery Therapeutics

Indication: Neurology

...a previously reported reference compound. Next steps include evaluating the lead compounds in animal models. Indus Biotech Pte. Ltd....
Items per page:
1 - 3 of 3
BioCentury | Jan 10, 2013
Distillery Therapeutics

Indication: Cardiovascular disease

...modulating necrosis via SIRT2 inhibition could have benefit in other indications, such as neurodegenerative diseases. Indus Biotech Pte. Ltd.'s...
BioCentury | Sep 20, 2012
Distillery Therapeutics

Indication: Neurology

...of Sirt2 deletion in other mouse models of PD and developing selective, brain-penetrant SIRT2 inhibitors. Indus Biotech Pte. Ltd....
BioCentury | Jun 28, 2012
Distillery Therapeutics

Indication: Neurology

...a previously reported reference compound. Next steps include evaluating the lead compounds in animal models. Indus Biotech Pte. Ltd....
Items per page:
1 - 3 of 3